Literature DB >> 22660809

Vascular leak is a central feature in the pathogenesis of systemic sclerosis.

Tracy M Frech1, Monica P Revelo, Stavros G Drakos, Maureen A Murtaugh, Boaz A Markewitz, Allen D Sawitzke, Dean Y Li.   

Abstract

OBJECTIVE: The main histopathological focus of systemic sclerosis (SSc) has concentrated on fibrotic changes. We investigated the microvasculature alterations in the skin of patients with SSc at various stages of disease duration with whole-field digital microscopy.
METHODS: Twenty consecutive patients with SSc, 1 with Raynaud's phenomenon (RP) without SSc, and 4 healthy controls underwent punch biopsy on the medial forearm. Eighteen patients were included in the primary analysis. Two with recent-onset diffuse cutaneous disease, 1 repeat SSc biopsy, and 1 patient with RP without SSc were also evaluated. All specimens were processed with histochemical stains and immunohistochemistry. We analyzed microvasculature abnormalities in an objective and systematic manner taking advantage of recent advances in whole-field digital microscopy. This analysis was coupled with ultrastructural evaluation performed with transmission electron microscopy (TEM).
RESULTS: Whole-field digital microscopy and TEM of SSc skin biopsies revealed that endothelial abnormalities are a universal feature regardless of clinical features and/or duration of disease. These features were not seen in any healthy control specimens or in the single RP patient samples. Whole-field digital microscopy identified increased interstitial edema (31.0% ± 9.6% vs 17.6% ± 3.3% in controls; p = 0.009) and fibrosis (75.6% ± 5.7% vs 66.1% ± 9.8% in controls; p = 0.02) in all patients with SSc. Lower CD34 staining was seen in SSc compared to healthy controls (0.32% ± 0.22% vs 1.31% ± 0.34%; p < 0.0001) and within the SSc population with interstitial lung disease (0.55% ± 0.22% vs 0.15% ± 0.16%; p = 0.01). Perivascular and interstitial infiltrate of mast cells was present in all SSc specimens.
CONCLUSION: Whole-field digital microscopy offers a means of rapidly carrying out objective, fully quantitative, and reproducible measurements of microscopic features of SSc microvascular change. The universal morphologically abnormal endothelial cells and interstitial edema in all patients with SSc biopsied suggests that SSc may be intrinsically a disease of the endothelium characterized by vascular leak.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22660809      PMCID: PMC3640272          DOI: 10.3899/jrheum.111380

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  46 in total

Review 1.  Systemic sclerosis. The role of the mast cell and cytokines.

Authors:  M Frieri
Journal:  Ann Allergy       Date:  1992-11

2.  Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma.

Authors:  R Sgonc; M S Gruschwitz; H Dietrich; H Recheis; M E Gershwin; G Wick
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

3.  Steady-state mRNA levels of collagens I, III, fibronectin, and collagenase in skin biopsies of systemic sclerosis patients.

Authors:  K Herrmann; M Heckmann; M Kulozik; U F Haustein; T Krieg
Journal:  J Invest Dermatol       Date:  1991-08       Impact factor: 8.551

Review 4.  Pathogenesis of scleroderma. Collagen.

Authors:  S A Jimenez; E Hitraya; J Varga
Journal:  Rheum Dis Clin North Am       Date:  1996-11       Impact factor: 2.670

5.  Mast cell changes in a case of rapidly progressive scleroderma-ultrastructural analysis.

Authors:  H N Claman
Journal:  J Invest Dermatol       Date:  1989-02       Impact factor: 8.551

Review 6.  CD34: structure, biology, and clinical utility.

Authors:  D S Krause; M J Fackler; C I Civin; W S May
Journal:  Blood       Date:  1996-01-01       Impact factor: 22.113

Review 7.  The diagnosis and classification of scleroderma (systemic sclerosis).

Authors:  A J Barnett; M Miller; G O Littlejohn
Journal:  Postgrad Med J       Date:  1988-02       Impact factor: 2.401

8.  Studies of the microvascular endothelium in uninvolved skin of patients with systemic sclerosis: direct evidence for a generalized microangiopathy.

Authors:  A J Freemont; J Hoyland; P Fielding; N Hodson; M I Jayson
Journal:  Br J Dermatol       Date:  1992-06       Impact factor: 9.302

9.  Sequential dermal microvascular and perivascular changes in the development of scleroderma.

Authors:  R J Prescott; A J Freemont; C J Jones; J Hoyland; P Fielding
Journal:  J Pathol       Date:  1992-03       Impact factor: 7.996

10.  Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.

Authors:  P Clements; P Lachenbruch; J Siebold; B White; S Weiner; R Martin; A Weinstein; M Weisman; M Mayes; D Collier
Journal:  J Rheumatol       Date:  1995-07       Impact factor: 4.666

View more
  17 in total

1.  Autophagy is a key feature in the pathogenesis of systemic sclerosis.

Authors:  Tracy Frech; Ivana De Domenico; Maureen A Murtaugh; Monica P Revelo; Dean Y Li; Allen D Sawitzke; Stavros Drakos
Journal:  Rheumatol Int       Date:  2013-08-11       Impact factor: 2.631

2.  Automated Measurement of Microvascular Function Reveals Dysfunction in Systemic Sclerosis: A Cross-sectional Study.

Authors:  Daniel R Machin; Phillip E Gates; Hans Vink; Tracy M Frech; Anthony J Donato
Journal:  J Rheumatol       Date:  2017-09-15       Impact factor: 4.666

3.  Systemic sclerosis induces pronounced peripheral vascular dysfunction characterized by blunted peripheral vasoreactivity and endothelial dysfunction.

Authors:  Tracy Frech; Ashley E Walker; Zachary Barrett-O'Keefe; Paul N Hopkins; Russell S Richardson; D Walter Wray; Anthony J Donato
Journal:  Clin Rheumatol       Date:  2014-12-16       Impact factor: 2.980

Review 4.  Sphingosine 1-phosphate receptor-targeted therapeutics in rheumatic diseases.

Authors:  Nathalie Burg; Jane E Salmon; Timothy Hla
Journal:  Nat Rev Rheumatol       Date:  2022-05-04       Impact factor: 20.543

5.  Exercise-induced brachial artery blood flow and vascular function is impaired in systemic sclerosis.

Authors:  Daniel R Machin; Heather L Clifton; Ryan S Garten; Jayson R Gifford; Russell S Richardson; D Walter Wray; Tracy M Frech; Anthony J Donato
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-09-30       Impact factor: 4.733

6.  Acute oral tetrahydrobiopterin administration ameliorates endothelial dysfunction in systemic sclerosis.

Authors:  Daniel R Machin; Heather L Clifton; Russell S Richardson; D Walter Wray; Anthony J Donato; Tracy M Frech
Journal:  Clin Exp Rheumatol       Date:  2017-09-14       Impact factor: 4.473

7.  The safety of iloprost in systemic sclerosis in a real-life experience.

Authors:  S Bellando-Randone; C Bruni; G Lepri; G Fiori; F Bartoli; M L Conforti; A Moggi-Pignone; S Guiducci; D Giuggioli; M Colaci; A Spinella; C Ferri; M Matucci-Cerinic
Journal:  Clin Rheumatol       Date:  2018-02-22       Impact factor: 2.980

8.  Gut disease in systemic sclerosis - new approaches to common problems.

Authors:  Jessica Zhu; Tracy Frech
Journal:  Curr Treatm Opt Rheumatol       Date:  2019-02-07

9.  Dissecting the Cellular Mechanism of Prostacyclin Analog Iloprost in Reversing Vascular Dysfunction in Scleroderma.

Authors:  Pei-Suen Tsou; Pamela J Palisoc; Nicholas A Flavahan; Dinesh Khanna
Journal:  Arthritis Rheumatol       Date:  2021-02-08       Impact factor: 10.995

10.  Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis.

Authors:  Angela Kill; Christoph Tabeling; Reinmar Undeutsch; Anja A Kühl; Jeannine Günther; Mislav Radic; Mike O Becker; Harald Heidecke; Margitta Worm; Martin Witzenrath; Gerd-Rüdiger Burmester; Duska Dragun; Gabriela Riemekasten
Journal:  Arthritis Res Ther       Date:  2014-01-28       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.